8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-22-303275
Bylaws or fiscal year change · Regulation FD disclosure · Other events
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d434402d8k.htm…